Holen Sie sich die Stockscreener-App
0.1656
10.39%
-0.0192
Handel nachbörslich:
.16
-0.0056
-3.38%
Schlusskurs vom Vortag:
$0.1848
Offen:
$0.1551
24-Stunden-Volumen:
4.62M
Relative Volume:
2.46
Marktkapitalisierung:
$7.17M
Einnahmen:
$6.14M
Nettoeinkommen (Verlust:
$-24.81M
KGV:
-0.0665
EPS:
-2.49
Netto-Cashflow:
$-27.40M
1W Leistung:
-20.00%
1M Leistung:
-58.39%
6M Leistung:
-74.68%
1J Leistung:
-92.47%
1-Tages-Spanne:
$0.1551
$0.1726
1-Wochen-Bereich:
$0.1551
$0.2237
52-Wochen-Spanne:
$0.1151
$2.315
Geovax Labs Inc Stock (GOVX) Company Profile
Firmenname
Geovax Labs Inc
Sektor
Branche
Telefon
678-384-7220
Adresse
1900 LAKE PARK DRIVE, SMYRNA
Vergleichen Sie GOVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.1656 | 8.00M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Bestätigt | Alliance Global Partners | Buy |
| 2025-04-15 | Bestätigt | D. Boral Capital | Buy |
| 2024-11-11 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-16 | Eingeleitet | ROTH MKM | Buy |
| 2020-11-19 | Eingeleitet | Maxim Group | Buy |
Geovax Labs Inc Aktie (GOVX) Neueste Nachrichten
Why GeoVax Labs Inc. Equity Warrant stock could be next big winnerTrade Performance Summary & AI Driven Stock Price Forecasts - ulpravda.ru
How GeoVax Labs Inc. stock benefits from strong dollarMarket Growth Report & Consistent Income Trade Ideas - ulpravda.ru
Will GeoVax Labs Inc. Equity Warrant stock split again soonBuy Signal & Daily Oversold Bounce Ideas - ulpravda.ru
What dividend safety score for GeoVax Labs Inc. Equity Warrant stockChart Signals & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is GeoVax Labs Inc. Equity Warrant stock safe for conservative investorsMarket Sentiment Summary & AI Powered Market Entry Ideas - ulpravda.ru
Is GeoVax Labs Inc. stock overvalued by current metricsTreasury Yields & Verified Swing Trading Watchlists - ulpravda.ru
How GeoVax Labs Inc. Equity Warrant stock reacts to inflationary pressuresCPI Data & Long-Term Capital Growth Ideas - ulpravda.ru
How currency fluctuations impact GeoVax Labs Inc. stockMarket Risk Report & Daily Entry Point Alerts - ulpravda.ru
Why GeoVax Labs Inc. stock remains undervalued2025 Market WrapUp & Stock Market Timing Techniques - ulpravda.ru
How GeoVax Labs Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Daily Stock Trend Watchlist - ulpravda.ru
Stop Loss: Why GeoVax Labs Inc. Equity Warrant stock remains a top recommendationWeekly Trend Recap & Smart Swing Trading Techniques - ulpravda.ru
Why GeoVax Labs Inc. Equity Warrant stock remains a top recommendation2025 Biggest Moves & Weekly Return Optimization Plans - ulpravda.ru
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement - The Globe and Mail
Why GeoVax Labs Inc. stock is popular among millennials2025 Price Momentum & Daily Profit Focused Stock Screening - ulpravda.ru
GeoVax Labs: Dividend historical data and projections - MarketScreener
GeoVax Labs: Target Price Consensus and Analysts Recommendations | GOVX | US3736786068 - MarketScreener
GeoVax Labs: Performance & Quotes, GOVX Stock Price on Nasdaq Exchange - MarketScreener
GeoVax Labs: Financial Data Forecasts Estimates and Expectations | GOVX | US3736786068 - MarketScreener
How GeoVax Labs Inc. stock reacts to bond yieldsChart Pattern Recognition & Low Cost Capital Growth - bollywoodhelpline.com
GeoVax Labs to Outline Clinical Progress and Strategic Priorities at Major Healthcare Conferences - citybuzz -
About Us - FinancialContent
Why GeoVax Labs Inc. stock appeals to dividend seekers2026 world cup usa national team quarterfinals key players counter attacking expert forecast analysis - ulpravda.ru
GOVX Stock Price, Forecast & Analysis | GEOVAX LABS INC (NASDAQ:GOVX) - Chartmill
GeoVax shareholders approve warrant exercises - MSN
GOVX News Today | Why did GeoVax Labs stock drop today? - MarketBeat
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy? - Defense World
Is GeoVax Labs Inc a good long term investmentSupport Level Holds & Big Returns Small Capital - Early Times
Sentiment Watch: Why GeoVax Labs Inc stock is favored by top institutionsQuarterly Performance Summary & Real-Time Market Sentiment Reports - moha.gov.vn
GeoVax Labs Inc Equity Warrant Stock Analysis and ForecastDividend Yield Trends & Best Stocks For Explosive Growth - earlytimes.in
Analyst Calls: What dividend safety score for GeoVax Labs Inc Equity Warrant stockQuarterly Trade Report & AI Powered Market Entry Ideas - moha.gov.vn
GeoVax Labs announces public equity offering for liquidity - MSN
Is Now the Best Entry Point for Orient Cement Limited StockCovered Call Writing & Fast Profit Strategies - earlytimes.in
GeoVax Labs Announces Public Equity Offering for Liquidity - The Globe and Mail
GeoVax Labs Signs Multiple Material Agreements - TradingView — Track All Markets
Market Wrap: Can GeoVax Labs Inc stock deliver sustainable ROE2025 Price Momentum & Expert Approved Momentum Ideas - moha.gov.vn
Why GeoVax Labs Inc. stock is recommended by analystsQuarterly Earnings Report & Proven Capital Preservation Methods - Улправда
Is GeoVax Labs Inc. stock a bargain at current levelsJuly 2025 Closing Moves & Safe Investment Capital Preservation Plans - Улправда
Can GeoVax Labs Inc. stock sustain institutional interestGold Moves & Fast Moving Trade Plans - Улправда
Analyst Downgrade: How GeoVax Labs Inc. Equity Warrant stock reacts to inflationary pressuresJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - Улправда
Why GeoVax Labs Inc. stock is a must watch in 20252025 Market Overview & Stock Portfolio Risk Management - Улправда
Would You Still Hold Geovax Labs Stock If It Fell Another 30%? - Trefis
Geovax Labs Stock Slides 61% With A 9-Day Losing Spree - Trefis
Will GeoVax Labs Inc. stock outperform Nasdaq indexPrice Action & Free Low Drawdown Momentum Trade Ideas - Улправда
GeoVax Announces $3.2 Million Public Offering to Fund Clinical-Stage Vaccine and Cancer Therapy Development - citybuzz -
Why GeoVax Labs Inc. stock attracts global investors2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results - Sahm
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering - Yahoo Finance
How GeoVax Labs Inc. Equity Warrant stock responds to policy changesJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - DonanımHaber
How GeoVax Labs Inc. stock performs after earnings2025 Support & Resistance & Verified Technical Trade Signals - DonanımHaber
Is GeoVax Labs Inc. Equity Warrant stock attractive for growth ETFs2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Can GeoVax Labs Inc. Equity Warrant stock beat market expectations this quarterMarket Sentiment Summary & Weekly Return Optimization Plans - DonanımHaber
Finanzdaten der Geovax Labs Inc-Aktie (GOVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Geovax Labs Inc-Aktie (GOVX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SPENCER JOHN N JR | Director |
Apr 10 '25 |
Buy |
0.98 |
10,000 |
9,800 |
11,402 |
| Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
| DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
| Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):